MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹477 Cr | ₹390 Cr | ₹341 Cr | ₹380 Cr | ₹299 Cr |
What is the latest Total Current Liabilities ratio of MARKSANS PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹477 Cr |
Mar2024 | ₹390 Cr |
Mar2023 | ₹341 Cr |
Mar2022 | ₹380 Cr |
Mar2021 | ₹299 Cr |
How is Total Current Liabilities of MARKSANS PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹477 Cr | 22.44 | |
Mar2024 | ₹390 Cr | 14.33 | |
Mar2023 | ₹341 Cr | -10.29 | |
Mar2022 | ₹380 Cr | 27.13 | |
Mar2021 | ₹299 Cr | - |
Compare Total Current Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹9,505.9 Cr | -7.2% | -17.6% | 7.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,917.0 Cr | -1.2% | -3.6% | -8.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,982.0 Cr | -6.6% | -12.4% | 22.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,306.0 Cr | 0.7% | 9.1% | 7.2% | Stock Analytics | |
CIPLA | ₹121,442.0 Cr | 0.3% | 1.2% | -5.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,752.0 Cr | 0.4% | -2.8% | -12.7% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -7.2% |
-17.6% |
7.1% |
SENSEX | -0.5% |
-3.1% |
1.4% |
You may also like the below Video Courses